Submitted by Anonymous (not verified) on 1 December 2023 - 13:45
Human medicines European public assessment report (EPAR): Adcetris, brentuximab vedotin, Lymphoma, Non-Hodgkin;Hodgkin Disease, Date of authorisation: 25/10/2012, Revision: 35, Status: Authorised
Source: